Hubei Biocause Pharmaceutical (000627) — Cash Flow Reinvestment Rate
Hubei Biocause Pharmaceutical (000627) has a Cash Flow Reinvestment Rate of 35.61x as of September 2023, reinvesting CN¥9.83 Billion (capex CN¥10.51 Million plus investments CN¥-9.82 Billion) from operating cash flow of CN¥276.06 Million. Check Hubei Biocause Pharmaceutical (000627) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Biocause Pharmaceutical Cash Flow Reinvestment Rate (2001–2023)
Historical reinvestment intensity for Hubei Biocause Pharmaceutical across 16 annual periods. Explore 000627 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year capital reinvestment analysis for Hubei Biocause Pharmaceutical. For live market cap and broader valuation context, see Hubei Biocause Pharmaceutical (000627) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.39x | CN¥3.71 Billion | CN¥9.53 Billion | CN¥67.53 Million | ▼ -81.4% |
| 2022 | 2.09x | CN¥15.75 Billion | CN¥7.52 Billion | CN¥135.06 Million | ▼ -64.4% |
| 2021 | 5.88x | CN¥24.52 Billion | CN¥4.17 Billion | CN¥287.13 Million | ▲ +854.9% |
| 2020 | 0.62x | CN¥13.18 Billion | CN¥21.42 Billion | CN¥319.51 Million | ▼ -60.7% |
| 2019 | 1.57x | CN¥44.77 Billion | CN¥28.60 Billion | CN¥717.10 Million | ▲ +38.1% |
| 2018 | 1.13x | CN¥16.99 Billion | CN¥14.98 Billion | CN¥274.67 Million | ▼ -97.2% |
| 2017 | 40.64x | CN¥17.54 Billion | CN¥431.58 Million | CN¥778.95 Million | ▲ +3589.5% |
| 2013 | 1.10x | CN¥143.80 Million | CN¥130.53 Million | CN¥143.80 Million | ▼ -19.6% |
| 2012 | 1.37x | CN¥128.50 Million | CN¥93.79 Million | CN¥128.50 Million | ▼ -38.6% |
| 2011 | 2.23x | CN¥149.37 Million | CN¥66.95 Million | CN¥149.37 Million | ▲ +438.3% |
| 2010 | 0.41x | CN¥93.09 Million | CN¥224.58 Million | CN¥93.09 Million | ▼ -24.1% |
| 2007 | 0.55x | CN¥64.76 Million | CN¥118.56 Million | CN¥64.76 Million | ▼ -46.2% |
| 2006 | 1.02x | CN¥130.12 Million | CN¥128.19 Million | CN¥130.12 Million | ▲ +101.5% |
| 2005 | 0.50x | CN¥24.51 Million | CN¥48.66 Million | CN¥24.51 Million | ▲ +10.7% |
| 2004 | 0.46x | CN¥25.52 Million | CN¥56.07 Million | CN¥25.52 Million | ▼ -46.0% |
| 2001 | 0.84x | CN¥31.47 Million | CN¥37.30 Million | CN¥31.47 Million | — |